retatrutide clinical trials fat loss Retatrutide: A Triple Agonist Shaping the Future of Metabolic Care Retatrutide for weight loss: Study

Our experience shows that financial uncertainty is one of the biggest reasons people hesitate to even begin their journey

Hormonal shifts, chronic inflammation, insulin resistance, and prolonged stress quietly change how your body responds even when your habits havent changed at all

Supporting that environment with the right bacteria and fiber is not just compatible with your treatment

Tirzepatide Semaglutide (Ozempic/Wegovy) activates GLP-1 receptors, which: Slows stomach emptying Reduces appetite Improves insulin sensitivity Typically results in 15-20% weight loss over a year Tirzepatide (Mounjaro/Zepbound) activates both GLP-1 and GIP receptors, which: Provides all semaglutide benefits May have stronger effects on glucose metabolism Often results in 20-25% weight loss over a year Sometimes has fewer gastrointestinal side effects Your optimal choice depends on your specific PCOS presentation

Link Lee, Y